On May 23, 2025 Section 4.A was updated.
On March 5 and 18, 2025, Sections 2.B, 3.D, 4.B, 5.A, and 5.D were updated.
On February 5, 2025, Sections 3.E and 4.A were updated.
The United States Patent and Trademark Office (USPTO or Office) has developed a Director Review process for certain decisions made in Patent Trial and Appeal Board (PTAB or Board) proceedings under part 42 of 37 C.F.R. The Director Review process was codified in 37 C.F.R. § 42.75, effective October 31, 2024. See 89 FR 79744 (Oct. 1, 2024).
This page provides implementation details relating to the Director Review process. Please see the Revised Interim Director Review process section for historical information about the development of the Director Review process.
A listing of all Director Review grants, and the status of each Director Review request, may be found on the Status of Director Review requests page.
1. Purpose of Director Review
In United States v. Arthrex, Inc., the Supreme Court explained that “constitutional principles chart a clear course: Decisions by [administrative patent judges (APJs)] must be subject to review by the Director.” 594 U.S. 1, 24 (2021). The Court held that “the Director has the authority to provide for a means of reviewing PTAB decisions” and “may review final PTAB decisions and, upon review, may issue decisions [themself] on behalf of the Board.” Id. at 25. Additionally, the Court in Arthrex made clear that “the Director need not review every decision of the PTAB” nor did it require the Director to accept requests for review or issue a decision in every case. Id. at 27. Instead, “[w]hat matters is that the Director have the discretion to review decisions rendered by APJs.’” Id.; see also Arthrex, Inc. v. Smith & Nephew, Inc., 35 F.4th 1328, 1338 (Fed. Cir. 2022) (noting that the Supreme Court “did not hold that the Director must rehear every Board decision, nor did it require the Director to issue a decision in response to every rehearing request”).
After receiving comments from the public as part of a Request for Comments and Notice of Proposed Rulemaking, the Office published Rules Governing Director Review of Patent Trial and Appeal Board Decisions on October 1, 2024, setting forth the process for the Director to review certain Board decisions. Further, although the Supreme Court’s decision in Arthrex “concern[ed] only the Director’s ability to supervise APJs in adjudicating petitions for inter partes review,” and “[did] not address the Director’s supervision over other types of adjudications conducted by the PTAB,” the Office also provides a mechanism for Director Review of certain other proceedings before the Board, e.g., post grant review proceedings and derivation proceedings. 594 U.S. at 26; 37 C.F.R. § 42.75(a).
2. Availability of Director Review
A. Overview
Moreover, although the issues for which a party may request Director Review are limited as defined below, the Director retains unilateral discretion to initiate Director Review of Board decisions sua sponte. 37 C.F.R. § 42.75(b).
B. Proceedings under part 42 of 37 C.F.R.
In a proceeding under part 42 of 37 C.F.R., and in lieu of filing a request for rehearing by the Board under 37 C.F.R. § 42.71(d), a party may file one request for Director Review of any decision on institution under 35 U.S.C. §§ 135, 314, or 324, any final decision under 35 U.S.C. §§ 135, 318, or 328, any decision granting rehearing of such a decision, or any other decision concluding a proceeding brought under 35 U.S.C. §§ 135, 311, or 321. 37 C.F.R. 42.75(c).
Requests for Director Review of a Board’s decision on institution under 35 U.S.C. §§ 135, 314, or 324, or decisions granting rehearing of such a decision, shall be limited to decisions presenting (a) an abuse of discretion, (b) important issues of law or policy, (c) erroneous findings of material fact, or (d) erroneous conclusions of law. Both discretionary and merits-based issues may be raised, subject to limitations (a)–(d) above. The Director Review process provides a mechanism to correct errors at the institution stage, for example, to avoid unnecessary trials for patent owners.
Requests for Director Review of a Board’s final decision under 35 U.S.C. §§ 135, 318, or 328, decisions granting rehearing of such a decision, or any other decision concluding a proceeding brought under 35 U.S.C. §§ 135, 311, or 321, shall be limited to decisions presenting (a) an abuse of discretion, (b) important issues of law or policy, (c) erroneous findings of material fact, or (d) erroneous conclusions of law. As a general matter, a request for Director Review of a final decision is not an opportunity to raise issues related to the Board’s decision on institution, for example, whether a petition meets the reasonable likelihood standard or how the Board exercised the Director’s institution discretion.
3. Requesting Director Review
A. Submission
Only a party to a proceeding before the Office may request Director Review. Third parties may not request Director Review or submit comments regarding a specific Director Review request or proceeding, aside from authorized amicus briefing. 37 C.F.R. § 42.75(g).
In a proceeding under part 42 of 37 C.F.R., a party may submit a Director Review request by filing a “Request for Director Review” in the Patent Trial and Appeal Case Tracking System (P-TACTS).
A party is limited to requesting Director Review or rehearing by the Board, but shall not request both. 37 C.F.R. § 42.75(c). An improper request for both Director Review and panel rehearing of the same decision will be treated as a request for Director Review only.
B. Timing
A timely request for Director Review will be treated as a request for rehearing under 37 C.F.R. § 90.3(b)(1) and will reset the time for appeal until after all issues on Director Review in the proceeding are resolved. 37 C.F.R. § 42.75(e)(3).
C. Formatting
D. Fees
The fee set forth in 37 C.F.R. § 42.15(f) is due on the filing of a request for Director Review.
E. Content
Subject to authorization by the Director, which may be requested by submitting an email to Director_PTABDecision_Review@uspto.gov, the submission of new evidence or arguments may be warranted in cases addressing issues of first impression or issues involving intervening changes in the law or USPTO procedures, guidance, or decisions.
Any argument not made within the request may be deemed waived.
A response to a request for Director Review is only permitted if authorized by the Director. For requests for Director Review filed on or after February 3, 2025, the USPTO will send an email to parties authorizing a response to the request. This will facilitate consideration by the Director. A response will be strictly limited to five pages and must be filed within five business days of the email. No new evidence may be filed with the response unless specifically authorized by the USPTO. Any such response must be filed in P-TACTS, i.e., by selecting the “Other: Other” paper type, and the paper must be titled “Authorized Response to Director Review Request” or else it may not be considered.
F. Processing
If the request is not compliant, the USPTO will attempt to work with the requesting party to rectify any areas of non-compliance. However, if the request is not compliant because it was submitted after the deadline, it will not be considered absent a good cause extension as discussed in Section 3.B above.
G. Communications
4. Determining Whether to Grant Director Review
A. Advisory Committee
As to important issues of law or policy, the Director will consult an Advisory Committee to provide a recommendation to the Director as to any issues under review. The Director may also consult the Advisory Committee to make recommendations on decisions that the Director is considering for sua sponte Director Review (see Section 4.C below).
i. Advisory Committee Purpose
ii. Advisory Committee Composition
- Office of the Under Secretary (not including the Director or Deputy Director)
- Patent Trial and Appeal Board (not including members of the panel for each case under review)
- Office of the Commissioner for Patents (not including the Commissioner for Patents or any persons involved in the examination of the challenged patent)
- Office of the General Counsel
- Office of Policy and International Affairs
Additional individuals, such as technical or subject matter experts, or others assisting in an administrative support capacity, may participate in the work of the Advisory Committee.
As to requests that raise an abuse of discretion, erroneous findings of material fact, or erroneous conclusions of law but do not otherwise raise important issues of law or policy, the Director will consult the Director Review Executive and at least two members of the Patent Trial and Appeal Board and may consult others in the Office as needed, so long as those individuals do not have a conflict of interest.
B. Director Review Determination
The Director receives each request for Director Review, the underlying decision along with the associated arguments and evidence, and the recommendation of the Director Review Executive. From this information, the Director determines whether to grant or deny Director Review, or to delegate further consideration of a decision to a Delegated Rehearing Panel (Section 5.A.iii below). When reviewing a decision on Director Review, the Director may review the Board’s decision on institution, the Board’s final decision, the Board’s decision granting rehearing of either of those decisions, or any other decision concluding a proceeding brought under 35 U.S.C. §§ 135, 311, or 321, which incorporate all matters and all orders entered in the proceeding. 37 C.F.R. § 42.75(a).
The USPTO strives to provide timely consideration of Director Review requests. The amount of time it takes to reach a decision depends on the complexity and number of issues raised.
C. Sua Sponte Director Review
If Director Review is initiated sua sponte by the Director, the parties to the proceeding will be given notice and may be given an opportunity for briefing. If briefing is requested, the USPTO will set forth the procedures to be followed.
Absent exceptional circumstances, the Director may initiate review sua sponte at any point within 21 days after the expiration of the period for filing a request for rehearing pursuant to 37 C.F.R. § 42.71(d), as appropriate to the type of proceeding for which review is sought, and before the filing of a notice of appeal under 37 C.F.R. § 90.3. 37 C.F.R. § 42.75(b).
5. Director Review
A. Process
As explained above, Director Review may be requested in a proceeding under part 42 of 37 C.F.R. where the Board’s decision on institution under 35 U.S.C. §§ 135, 314, or 324; the Board’s final decision under 35 U.S.C. §§ 135, 318, or 328; or the Board’s decision granting rehearing of either a decision on institution or a final decision implicates potential (a) abuse of discretion, (b) important issues of law or policy, (c) erroneous findings of material fact, or (d) erroneous conclusions of law.
The Director’s decision to grant or deny a request will be communicated directly to the parties in the proceeding. Director Review grants also will be posted on the Status of Director Review requests webpage. Director Review denials can be found on the Director Review status spreadsheet, which is updated monthly.
i. Denial of Director Review
ii. Grant of Director Review
a) Grant Order
The Director may issue an initial order granting review and identifying the issue(s) to be addressed. Alternatively, the Director may issue a single decision that grants Director Review and resolves the identified issue(s) in the first instance. In such a circumstance, the Director will resolve the pertinent issue(s) based on the existing record.
b) Briefing, Discovery, and Oral Argument
Responsive or amici curiae briefing may only be submitted if requested by the Director. If a request for either is made by the Director, the USPTO will set forth the procedures to be followed.
Any amicus brief submitted by a party with whom the Director has a conflict will be stricken. This process is consistent with Federal Rule of Appellate Procedure 29(a)(2) as adopted by the United States Court of Appeals for the Federal Circuit.
Director Review decisions also are generally made based on the existing record, without the need for additional discovery. However, the Director has discretion to order additional discovery if the Director deems necessary to assist the Director in evaluating the issues presented. 35 U.S.C. § 316(a)(5) (“The Director shall prescribe regulations . . . setting forth standards and procedures for discovery of relevant evidence . . . otherwise necessary in the interest of justice.”); 37 C.F.R. § 42.5(a).
Additionally, the Director has the discretion to order an oral hearing.
c) Standard of Review
Decisions of the Board under Director Review are reviewed de novo.
Upon review, the Director may – in whole or in part – affirm, reverse, modify, vacate, or remand the decision to the Board for further proceedings. The Director may make any findings or conclusions that the Director deems proper based on the record.
d) Relation to Underlying Proceeding
For example, if Director Review of the Board’s decision to institute under 35 U.S.C. §§ 135, 314, or 324 is granted, the underlying trial on the merits is not stayed. The Director may delegate authority back to the Board to handle routine interlocutory matters, conduct conference calls, or attend to other matters outside of the intended scope of the Director Review. If authority is so delegated, the Board will keep the Director apprised of these matters and provide reasonable prior notice of any intended decision, but the Board may handle matters so delegated without direction from the Director.
e) Remands to the Board
When issuing a decision upon remand from the Director, the Board shall decide the matter independently and without direction from the Director. See SOP 4: Procedure for Pre-Issuance Optional Decision Review and Post-Issuance Decision Review; 37 C.F.R Part 43.
Where the Board issues a decision on remand from the Director, a party may file one request for Director Review of the Board’s decision on remand. The Director may also initiate sua sponte Director Review of a remanded decision at their discretion.
f) Sanctions
iii. Delegated Rehearing Panel
For example, the Director may designate a DRP to consider whether a material issue of fact or law was misapprehended or overlooked by the Board. When the Director determines to delegate review of a decision to the DRP, the Director will issue an order identifying that review has been delegated to the DRP. In the event that the Director delegates a decision to the DRP to conduct review, including when the Director delegates review of a decision sua sponte to the DRP, the DRP panel will determine whether to grant rehearing. You can find more information on the Delegated Rehearing Panel at the Delegated Rehearing Panel web page.
B. Effect of Director Review Decisions
Routine Director Review decisions may be nominated for precedential or informative designation, and such nominations will follow the procedure set forth in SOP 2. If a Director Review decision is designated as precedential or informative, it will be added to the PTAB’s precedential and informative webpage and an email notification will be issued to inform the public of its precedential or informative designation. Stakeholders and the public may submit nominations for precedential or informative designation using the PTAB Decision Nomination web form, which may be submitted anonymously, or by sending an email to PTAB_Decision_Nomination@uspto.gov.
This process places no limitation on the authority of the Director to designate or de-designate an issued decision or portion thereof as precedential or informative at any time, at the Director's sole discretion.
C. Review of Director Review Decisions
i. Appeal
A request for Director Review of a final decision, a decision granting rehearing of a final decision, or any other appealable decision concluding a proceeding brought under 35 U.S.C. §§ 135, 311, or 321, or the initiation of a review on the Director’s own initiative of such a decision, will be treated as a request for rehearing under 37 C.F.R. § 90.3(b)(1) and will reset the time for appeal until after all issues on Director Review in the proceeding are resolved. 37 C.F.R. § 42.75(e)(3).
ii. Requests for Rehearing
A party dissatisfied with a Director Review decision may file a single request for rehearing without prior authorization, and that party carries the burden of showing the Director Review decision should be modified. A party requesting rehearing must also email the Director at Director_PTABDecision_Review@uspto.gov, copying counsel for all parties to the proceeding. A response to a request for rehearing is not permitted unless expressly authorized. A party must not file a request for rehearing of a decision by the Director to deny Director Review.
A party may submit a request for rehearing of a Director Review decision in accordance with the submission requirements identified above, including the timing, page limits, and formatting requirements set forth above.
During the pendency of a request for rehearing of a Director Review decision, jurisdiction over the proceeding remains solely with the Director. The Board may not take any action in the proceeding while the request for rehearing is pending, without express authorization from the Director.
D. Conflicts of Interest
If the Director, the Director Review Executive, a consulting member of the PTAB, a member of the Advisory Committee, or other USPTO employee has a conflict of interest, they shall recuse themselves from the Director Review process for that decision.
In determining whether a conflict of interest exists, the USPTO follows the guidance set forth in the Standards of Ethical Conduct for Employees of the Executive Branch at 5 C.F.R. Part 2635 and will consult with the Department of Commerce Ethics Law and Programs Office, as necessary, to resolve any questions pertaining to conflicts of interest. Conflicts may include, for example, involvement in the examination or prosecution of the underlying patent or a related patent at issue. Further information is available in the U.S. Department of Commerce USPTO Summary of Ethics Rules.
Additionally, the Office has set forth procedures that the Office will follow in the event of an actual or potential conflict of interest by the Director of the USPTO. See Director Recusal Procedure Memorandum.
As a matter of policy, the Director Review Executive and PTAB Administrative Patent Judges who consult with the Director or are also Advisory Committee members will additionally follow the guidance on conflicts of interest set forth in the PTAB’s SOP 1 and will recuse themselves from any discussion or analysis involving cases or related cases on which they are paneled.
E. Status and Questions
If a party has additional questions regarding the implications of Director Review for a particular proceeding, they can submit case-specific questions (e.g., request a call with the PTAB) to Director_PTABDecision_Review@uspto.gov.
If a member of the public has a general question regarding Director Review but does not have a case pending before the PTAB, they can submit that question to Director_PTABDecision_Review@uspto.gov.
The information below describes an interim process that is no longer in effect. It was replaced by the above Director Review Process codified at 37 CFR § 42.75 on October 31, 2024.
Interim process no longer in effect as of October 31, 2024
1. Superseded - Purpose of Director Review
The Under Secretary of Commerce for Intellectual Property and Director of the USPTO (Director) is a statutory member of the Board. 35 U.S.C. § 6(a). The Director is “responsible for providing policy direction and management supervision for the Office,” id. § 3(a)(2)(A), and has “the authority to govern the conduct of proceedings in the Office,” id. § 2(b)(2)(A). The Director has an interest in creating binding guidance to increase fairness and efficiency, and for establishing consistency across Board proceedings.
In United States v. Arthrex, Inc., the Supreme Court explained that “constitutional principles chart a clear course: Decisions by [administrative patent judges (APJs)] must be subject to review by the Director.” 141 S. Ct. 1970, 1986 (2021). The Court held that “the Director has the authority to provide for a means of reviewing PTAB decisions” and “may review final PTAB decisions and, upon review, may issue decisions himself on behalf of the Board.” Id. at 1987 (citations omitted). Additionally, the Court in Arthrex made clear that “the Director need not review every decision of the PTAB” nor did it require the Director to accept requests for review or issue a decision in every case. Id. at 1988. Instead, “[w]hat matters is that the Director have the discretion to review decisions rendered by APJs.’” Id.; see also Arthrex, Inc. v. Smith & Nephew, Inc., 35 F.4th 1328, 1338 (Fed. Cir. 2022) (noting that the Supreme Court “did not hold that the Director must rehear every Board decision, nor did it require the Director to issue a decision in response to every rehearing request”).
Accordingly, following the statutory authority provided to the Director by Congress and the constitutional principles explained by the Supreme Court, the Office set forth an interim process for the Director to review Board decisions on June 29, 2021. On April 22, 2022, the Office published an “Interim process for Director Review web page,” setting forth more details on the interim process and some additional suggestions for parties who wish to request Director Review. The Office further updated that guidance on May 25, 2022, and June 17, 2022. The Office sought public feedback on the interim process through a Request for Comments posted in the Federal Register on July 20, 2022. The comment period closed on October 19, 2022. The Office received 4,377 comments which are publicly available.
In response to those comments and as the Office works to formalize the Director Review process, the Office sets forth the following revised interim process for the Director to review Board decisions. Further, although the Court’s decision in Arthrex “concern[ed] only the Director’s ability to supervise APJs in adjudicating petitions for inter partes review,” and “[did] not address the Director’s supervision over other types of adjudications conducted by the PTAB,” the Office also provides a mechanism for Director Review of certain other proceedings before the Board, i.e., post grant review proceedings, derivation proceedings, and decisions whether to institute in AIA trial proceedings. 141 S. Ct. at 1987.
2. Superseded - Availability of Director Review
A. Overview
In Arthrex, the Supreme Court exclusively addressed the Director’s ability to review final decisions of the Board in inter partes review proceedings. 141 S. Ct. at 1987. The Court did not address the Board’s other areas of jurisdiction. Id. Nonetheless, for consistency and uniformity, Director Review requests are available for other areas of Board jurisdiction. Specifically, a party to a Board decision may now request Director Review of the Board’s (1) decision whether to institute a trial, (2) final written decision, or (3) decision granting a request for rehearing, subject to the requirements set forth below.
Moreover, although the issues for which a party may request Director Review are limited as defined below, the Director retains unilateral discretion to initiate Director Review of Board decisions sua sponte, as discussed in Section 4.C below.
B. AIA Trial Proceedings
In AIA trial proceedings under part 42 of 37 C.F.R., and in lieu of filing a request for rehearing by the Board under 37 C.F.R. §42.71(d), a party may only seek Director Review of the Board’s (1) decision whether to institute a trial, (2) final written decision, or (3) decision granting a request for rehearing.
Requests for Director Review of the Board’s decision whether to institute an AIA trial, or decisions granting rehearing of such a decision, shall be limited to decisions presenting (a) an abuse of discretion or (b) important issues of law or policy. Both discretionary and merits-based issues may be raised, subject to limitations (a) and (b) above.
Requests for Director Review of the Board’s final written decision, or decisions granting rehearing of such a decision, shall be limited to decisions presenting (a) an abuse of discretion, (b) important issues of law or policy, (c) erroneous findings of material fact, or (d) erroneous conclusions of law.
3. Superseded - Requesting Director Review
A. Submission
The How to File a Director Review Request guide provides step-by-step instructions on how to file the request.
Only a party to a proceeding before the Office may request Director Review. Third parties may not request Director Review or submit comments concerning the review of a decision.
In inter partes review, post grant review, and derivation proceedings, a party may submit a Director Review request by concurrently: (1) filing a Request for Rehearing by the Director in the Patent Trial and Appeal Case Tracking System (P-TACTS); and (2) emailing the Director at Director_PTABDecision_Review@uspto.gov, copying counsel for all parties to the proceeding. A Director Review request is not perfected until both submissions are made.
To ensure thorough and timely consideration of each Director Review request, the requesting party shall provide, in the notification email, a priority-ranked list of the issues for which the party seeks review, in the rare instance where a party has more than one issue to raise. This list shall include an express identification of the alleged (a) abuse of discretion, (b) important issue of law or policy, (c) erroneous finding of material fact, and/or (d) erroneous conclusions of law, as appropriate to the type of decision for which review is sought.
In the notification email, requesting parties may also provide a brief explanation of the issue(s) and a brief explanation of the rationale for the prioritized-ranking of the issue. The brief explanation should not exceed a few sentences and is not a substitute for formal arguments on the record.
If the requesting party believes that the request presents an issue of first impression, the notification email shall so indicate.
A party is limited to requesting Director Review or rehearing by the Board, but shall not request both. An improper request for both Director Review and panel rehearing of the same decision will be treated as a request for Director Review only.
B. Timing
A request for Director Review shall be filed within the time prescribed for a request for rehearing under 37 C.F.R. § 42.71(d), as appropriate to the type of proceeding for which review is sought. If a request is untimely, it is not considered.
A timely request for Director Review, pursuant to Section 3.A, is considered a request for rehearing under 37 C.F.R. § 90.3(b) and resets the time for appeal as set forth in that rule.
The Director may, upon a showing of good cause, extend the time period set forth above.
C. Formatting
A Request for Rehearing by the Director shall be subject to the length limitations (i.e., 15 pages) for motions to the Board provided in 37 C.F.R. § 42.24(a)(1)(v). The request must also conform to the applicable formatting requirements of 37 C.F.R. § 42.6(a).
D. Fees
Currently, the USPTO does not charge a fee for a Request for Rehearing by the Director. The USPTO may consider whether to charge a fee for such requests in the future.
E. Content
A Request for Rehearing by the Director may not introduce new evidence and, accordingly, exhibits may not be entered in support of the request. The Director will not consider new evidence or new arguments not part of the official record.
Subject to authorization by the Director, which may be requested by submitting an email to Director_PTABDecision_Review@uspto.gov, exceptions regarding new evidence or arguments may be warranted in cases addressing issues of first impression or issues involving intervening changes in the law or USPTO procedures, guidance, or decisions.
Any argument not made within the Request may be deemed waived.
A response to a request for Director Review is only permitted if authorized by the Director. For requests for Director Review filed on or after February 3, 2025, the USPTO will send an email to parties authorizing a response to the request. This will facilitate consideration by the Director. A response will be strictly limited to five pages and must be filed within five business days of the email. No new evidence may be filed with the response unless specifically authorized by the USPTO. Any such response must be filed in P-TACTS, i.e., by selecting the “Other: Other” paper type and the paper must be titled “Authorized Response to Director Review Request” or else it may not be considered.
F. Processing
After a party submits a request for Director Review, the Office will catalog the request and review it to ensure compliance with the applicable requirements. If the request is compliant, the notification email and the Request for Rehearing by the Director will be entered into the record of the corresponding proceeding. The request will be entered as “Exhibit 3100 – Director Review Request.”
If the request is not compliant, the USPTO will attempt to work with the party making the request to rectify any areas of non-compliance. However, if the request is not compliant because it was submitted after the deadline, it will not be considered absent a good cause extension as discussed in Section 3.B above.
G. Communications
All communications from a party to the Office during the pendency of Director Review must copy (cc) counsel for all parties to the proceeding. All communications will be entered into the record of the proceeding.
4. Superseded - Determining Whether to Grant Director Review
A. Advisory Committee
As to important issues of law or policy, the Director will consult an Advisory Committee to provide a recommendation to the Director as to any issues under review. The Director may also consult the Advisory Committee to make recommendations on decisions that the Director is considering for sua sponte Director Review (see Section 4.C below).
i. Advisory Committee Purpose
The Advisory Committee provides a singular recommendation to the Director that includes a consensus recommendation from various business units of the Office, or notes differing views among the Advisory Committee members.
The Advisory Committee provides its recommendations to the Director at regular intervals, promoting the timely consideration of Director Review requests.
ii. Advisory Committee Composition
The Advisory Committee includes one representative from each of the following five business units of the USPTO:
- Office of the Under Secretary (not including the Director or Deputy Director)
- Patent Trial and Appeal Board (not including members of the panel for each case under review)
- Office of the Commissioner for Patents (not including the Commissioner for Patents or any persons involved in the examination of the challenged patent)
- Office of the General Counsel
- Office of Policy and International Affairs
Additional individuals, such as technical or subject matter experts, or others assisting in an administrative support capacity, may participate in the work of the Advisory Committee .
As to requests that raise an abuse of discretion, erroneous findings of material fact, or erroneous conclusions of law but do not otherwise raise important issues of law or policy, the Director will consult the Director Review Executive and at least two members of the Patent Trial and Appeal Board and may consult others in the Office as needed, so long as those individuals do not have a conflict of interest.
B. Director Review Determination
The Director receives each request for Director Review, the underlying decision including the associated arguments and evidence, and the recommendation of the Advisory Committee. From this information, the Director determines whether to grant or deny Director Review, or to delegate further consideration of a decision to a Delegated Rehearing Panel (Section 5.A.iii below). When reviewing a decision on Director Review, the Director may review the Board’s decision whether to institute trial, the Board’s final written decision, or the Board’s decision granting rehearing of either of those decisions, which incorporate all matters and all orders entered in the proceeding.
The USPTO strives to provide timely consideration of Director Review requests. The amount of time it takes to reach a decision depends on the complexity and number of issues raised.
C. Sua Sponte Director Review
The Director may grant review of Board decisions sua sponte (on the Director’s own initiative). An order for sua sponte Director Review is treated like a timely request for rehearing for the purposes of 37 C.F.R. § 90.3(b) and, therefore, resets the time for appeal to no later than sixty-three (63) days after final resolution of the Director Review process. Typically, however, sua sponte Director Review is reserved for issues of exceptional importance. The PTAB has an internal post-issuance review team that alerts the Director that an issued decision may warrant Director Review. The Director retains authority to initiate review sua sponte of any other issue, as the Director deems appropriate, within the timeframe noted below.
If Director Review is initiated sua sponte by the Director, the parties to the proceeding will be given notice and may be given an opportunity for briefing. If briefing is requested, the USPTO will set forth the procedures to be followed.
Absent exceptional circumstances, the Director may initiate review sua sponte at any point within 21 days after the expiration of the period for filing a request for rehearing pursuant 37 C.F.R. § 42.71(d), as appropriate to the type of proceeding for which review is sought, and before the filing of a notice of appeal under 37 C.F.R. § 90.3.
5. Superseded - Director Review
A. Process
As explained above, Director Review may be requested in:
- AIA trial proceedings where the Board’s decision whether to institute trial, or the Board’s decision granting rehearing of such a decision, implicates potential (a) abuse of discretion or (b) important issues of law or policy; and
- AIA trial proceedings where the Board’s final written decision, or the Board’s decision granting rehearing of such a decision, implicates potential (a) abuse of discretion, (b) important issues of law or policy, (c) erroneous findings of material facts, or (d) erroneous conclusions of law.
The Director’s decision to grant or deny a request will be communicated directly to the parties in the proceeding. Director Review grants also will be posted on the Status of Director Review requests web page. Director Review denials can be found on the Director Review status spreadsheet, which is updated monthly.
i. Denial of Director Review
In cases where the Director determines to deny review, an order denying the request will be transmitted to the parties and entered into the record. The Director need not provide reasons for denial.
ii. Grant of Director Review
a) Grant Order
In cases where the Director determines to grant review, whether from a party request or sua sponte, the Director will issue a paper so stating, which will be transmitted to the parties and entered into the record.
The Director may issue an initial order granting review and identifying the issue(s) to be addressed. Alternatively, the Director may issue a singular decision, which both grants Director Review and resolves the identified issue(s) in the first instance. In such a circumstance, the Director will resolve the pertinent issue(s) based on the existing record.
b) Briefing, Discovery, and Oral Argument
Responsive or amici curiae briefing may only be submitted if requested by the Director. If a request for either is made by the Director, the USPTO will set forth the procedures to be followed.
Any amicus brief submitted by a party with whom the Director has a conflict will be struck. This process is consistent with Federal Rule of Appellate Procedure 29(a)(2) as adopted by the United States Court of Appeals for the Federal Circuit.
Director Review decisions also are generally made based on the existing record, without the need for additional discovery. However, the Director has discretion to order additional discovery the Director deems necessary to assist the Director in evaluating the issues presented. 35 U.S.C. § 316(a)(5) (“The Director shall prescribe regulations setting forth standards and procedures for discovery of relevant evidence . . . otherwise necessary in the interest of justice”); 37 C.F.R. § 42.5(a).
Additionally, the Director has the discretion to order an oral hearing.
c) Standard of Review
Decisions of the Board under Director Review are reviewed de novo.
Upon review, the Director may – in whole or in part – affirm, reverse, modify, vacate, or remand the decision to the Board for further proceedings. The Director may make any findings or conclusions that the Director deems proper based on the record.
d) Relation to Underlying Proceeding
By default, the grant of Director Review does not stay the underlying proceeding before the Board; however, the Director maintains authority over all issues in the case during the pendency of Director Review, unless the Director orders otherwise. If a stay of the underlying proceeding is imposed, the Director will issue an order so stating.
For example, if Director Review of the Board’s decision to institute an AIA trial is granted, the underlying trial on the merits is not stayed. The Director may delegate authority back to the Board to handle routine interlocutory matters, conduct conference calls, or attend to other matters outside of the intended scope of the Director Review. If authority is so delegated, the Board will keep the Director apprised of these matters and provide reasonable prior notice of any intended decision, but the Board may handle matters so delegated without direction from the Director.
e) Remands to the Board
In cases where the Director remands a decision to the Board for further proceedings, absent a due date specified in the Director’s remand order or extension thereof, the Board has established a goal to issue decisions in cases remanded from the Director as soon as possible. Even for the most complex records, for example, those that may require additional discovery, briefing, and/or an oral hearing, the Board’s goal is to issue the decision within six months of the date of the remand unless a due date is specified in the remand order. Accord SOP 3 (rev 2, formerly SOP 9): Procedure for Decisions Remanded from the Federal Circuit for Further Proceedings. The procedure and pace of a remand will vary depending on the type of case, the legal and factual issues involved, the specific instructions from the Director, and any other particular circumstances of the case. Upon remand, the Board will issue an order setting forth the date by which a decision on remand will issue.
When issuing a decision upon remand from the Director, the Board shall decide the matter independently and without direction from the Director. See SOP 4: Procedure for Pre-Issuance Optional Decision Review and Post-Issuance Decision Review.
Where the Board issues a decision on remand from the Director, a party may file one request for Director Review of the Board’s decision on remand. The Director may also initiate sua sponte Director Review of a remanded decision at her or his discretion.
f) Sanctions
The Director has authority to impose sanctions against a party for misconduct committed during the course of Director Review. 35 U.S.C. § 316(a)(6) (“The Director shall prescribe regulations . . . prescribing sanctions for abuse of discovery, abuse of process, or any other improper use of the proceeding, such as to harass or to cause unnecessary delay or an unnecessary increase in the cost of the proceeding.”); 37 C.F.R. §§ 42.11(d) (providing sanctions for misrepresentations), 42.12 (providing a non-exclusive list of misconduct and sanctions); Apple Inc. v. Voip-Pal.com, Inc., 976 F.3d 1316, 1323–4 (Fed. Cir. 2020) (“Section 42.12(b) does not limit the Board to the eight listed sanctions. Rather, the plain reading of Section 42.12(b) allows the Board to issue sanctions not explicitly provided in the regulation.”).
iii. Delegated Rehearing Panel
In consideration of the objectives of the Director Review process, the USPTO has set forth processes and procedures for the Director, at her or his discretion, to delegate review of a Board decision to a Delegated Rehearing Panel (DRP). That delegation may occur in cases where Director Review has been requested by a party, or may occur sua sponte, on the Director’s own initiative.
For example, the Director may designate a DRP to consider whether a material issue of fact or law was misapprehended or overlooked by the Board. When the Director determines to delegate review of a decision to the DRP, the Director will issue an order identifying that review has been delegated to the DRP. In the event that the Director delegates a decision to the DRP to conduct review, including when the Director delegates review of a decision sua sponte to the DRP, the DRP panel will determine whether to grant rehearing. More information on the Delegated Rehearing Panel can be found at the Delegated Rehearing Panel web page.
B. Effect of Director Review Decisions
Director Review decisions may be issued as precedential, informative, or routine decisions. Director Review decisions are, by default, routine decisions as set forth in Standard Operating Procedure 2 (SOP 2).
Routine Director Review decisions may be nominated for precedential or informative designation, and such nominations will follow the procedure set forth in SOP 2. If a Director Review decision is designated as precedential or informative, it will be added to the PTAB’s precedential and informative web page and an email notification will be issued to inform the public of its precedential or informative designation. Stakeholders and the public may submit nominations for precedential or informative designation using the PTAB Decision Nomination web form, which may be submitted anonymously, or by sending an email to PTAB_Decision_Nomination@uspto.gov.
This process places no limitation on the authority of the Director to designate or de-designate an issued decision or portion thereof as precedential or informative at any time, at the Director's sole discretion.
C. Review of Director Review Decisions
i. Appeal
Director Review decisions of Final Written Decisions in AIA trial proceedings are appealable to the United States Court of Appeals for the Federal Circuit using the same procedures for appealing other Board decisions. 35 U.S.C. §§ 141(c), 319. Director Review decisions of Board decisions on institution are not appealable. 35 U.S.C. § 314(d); Thryv, Inc. v. Click-to-Call Techs., LP, 140 S.Ct. 1367 (2020).
ii. Requests for Rehearing
Within the time frame allotted under 37 C.F.R. § 42.71(d), a party may file one request for rehearing of a Director Review decision, subject to the requirements explained below. Such requests should be rare, however, and only for very focused purposes. A request for rehearing of a Director Review decision is not an opportunity to raise new issues, reargue issues, or disagree with determinations by the Director. Instead, the rehearing request must specifically identify what matter the Director Review decision misapprehended or overlooked. Accord 37 C.F.R. § 42.71(d).
A party dissatisfied with a Director Review decision may file a single request for rehearing without prior authorization, and that party carries the burden of showing the Director Review decision should be modified. A party requesting rehearing must also email the Director at Director_PTABDecision_Review@uspto.gov,copying counsel for all parties to the proceeding. A response to a request for rehearing is not permitted unless expressly authorized. A party may not file a request for rehearing of the Director’s decision to deny Director Review.
A party may submit a request for rehearing of a Director Review decision in accordance with the submission requirements identified above, including the timing, page limits, and formatting requirements set forth above.
During the pendency of a request for rehearing of a Director Review decision, jurisdiction over the proceeding remains solely with the Director. The Board may not take any action in the proceeding while the request for rehearing is pending, without express authorization from the Director.
D. Conflicts of Interest
If the Director, a member of the Advisory Committee, any DRP or Board member, or other USPTO employee has a conflict of interest, they shall recuse themselves from the Director Review process for that decision.
In determining whether a conflict of interest exists, the USPTO follows the guidance set forth in the Standards of Ethical Conduct for Employees of the Executive Branch at 5 C.F.R. Part 2635 and will consult with the Department of Commerce Ethics Law and Programs Office, as necessary, to resolve any questions pertaining to conflicts of interest. Conflicts may include, for example, involvement in the examination or prosecution of the underlying patent or a related patent at issue.
Additionally, the Office has set forth procedures that the Office will follow in the event of an actual or potential conflict of interest by the Director or Deputy Director of the USPTO. See "Director Recusal Procedures" at Office of the Under Secretary and Director.
As a matter of policy, PTAB Administrative Patent Judges who are also Advisory Committee or DRP members will additionally follow the guidance on conflicts of interest set forth in the PTAB’s Standard Operating Procedure 1 and will recuse themselves from any discussion or analysis involving cases or related cases on which they are paneled.
E. Status and Questions
The status of Director Review requests can be found on the Status of Director Review requests web page. Parties may further inquire as to the status of their request by submitting an email to Director_PTABDecision_Review@uspto.gov or by calling the PTAB at (571) 272-9797.
If a party has additional questions regarding the implications of Director Review for a particular proceeding, they can submit case-specific questions (e.g., request a call with the PTAB) to Director_PTABDecision_Review@uspto.gov.
If a member of the public has a general question regarding Director Review but does not have a case pending before the PTAB, they can submit that question to Director_PTABDecision_Review@uspto.gov.